-
Jan 09 |
Diagnostics World | In the next phase of breath diagnostics, there is a promising area for future research: expanding upon the notion of “breath diagnostics” to leverage volatile organic compounds (VOCs) from elsewhere. VOCs from urine could be used to detect prostate cancer, for example. If looked at carefully with the right AI tools, leveraging VOCs could lead to compelling healthcare solutions down the road.
More
-
Jan 08 |
Diagnostics World | An international team of researchers hope to identify molecular and cellular level changes in muscle tissue that can be used to help diagnose and treat chronic fatigue syndrome (CFS) and long COVID. The quest is being pursued from both the physiological and electrical perspectives to better understand the muscle damage seen with the debilitating and still-mysterious conditions that share some striking similarities.
More
-
Jan 07 |
Diagnostics World | 2024 was full of innovative ideas and achievements. We spoke with industry experts and leaders about what to expect in the new year. Here are the full predictions and trends, including more information on the impact of AI/ML, spatial biology, antimicrobial resistance, and more.
More
-
Jan 03 |
Diagnostics World | 2024 was a packed year for diagnostics, starting with the FDA’s final rule amending the agency’s regulations to clarify in vitro diagnostics (IVDs). Companion diagnostics (CDx) also made great strides. Plus: Babson Diagnostics has a new blood testing that does what Theranos claimed to do. Here are the top stories of Diagnostic World News and thoughts from industry leaders.
More
-
Dec 27 |
Diagnostics World | PathAI launches the AIM-IHC Breast Panel; electronRx plans purpleDx, a cardiopulmonary assessment app; and more.
More
-
Dec 23 |
Diagnostics World | Adcendo plans to advance ADC programs; Beta Bionics to expand iLet Bionic Pancreas; and more.
More
-
Dec 17 |
Diagnostics World | Sepsis ImmunoScore, the first FDA-authorized AI diagnostic for sepsis, has high accuracy for the diagnosis of sepsis and for prediction of key adverse patient outcomes, reports a paper published last week in the New England Journal of Medicine AI. In the paper, the authors write that the test showed both diagnostic and prognostic power.
More
-
Dec 12 |
Diagnostics World | Sepsis ImmunoScore, the first FDA-authorized AI diagnostic for sepsis, has high accuracy for the diagnosis of sepsis and for prediction of key adverse patient outcomes, reports a paper published last week in the New England Journal of Medicine AI. In the paper, the authors write that the test showed both diagnostic and prognostic power.
More
-
Dec 11 |
Diagnostics World | A trio of publicly traded powerhouse companies—South Korea-based molecular diagnostics company Seegene, artificial intelligence (AI) and cloud service provider Microsoft, and global research publisher Springer Nature—are collaborating on an ambitious technology-sharing initiative that aims to better prepare the world for the next pandemic.
More
-
Dec 10 |
Diagnostics World | A number of research groups, companies, and collaboratives are pursuing breathalyzers aimed at tuberculosis, malaria, and other infectious diseases. Some of those same entities, and others, have also set their sights on applying breath-based technologies to a variety of other health concerns, including breast cancer, liver disease, gastrointestinal conditions, and lung disease.
More
-
Jan 09 |
Leica Biosystems and Indica Labs today announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs.
More
-
Jan 09 |
PrecisionLife announces the appointment of Bill Keating as Chief Commercial Officer, Diagnostics and Healthcare.
More
-
Jan 08 |
ClearNote Health announced that its Avantect Multi-Cancer Detection Test was selected for the National Cancer Institute’s new Vanguard Study.
More
-
Jan 08 |
Vergent Bioscience announced that the U.S. Food & Drug Administration has granted Fast Track designation for the company’s novel, investigational tumor-targeted fluorescent imaging agent, abenacianine for injection (VGT-309), as an adjunct for the intraoperative visualization of primary lung cancer, other pulmonary lesions, cancer containing lymph nodes, and positive surgical margins in patients undergoing surgery for known or suspected cancer in the lung.
More
-
Dec 19 |
ClearNote Health's Avantect Pancreatic Cancer test was selected for a large UK NHS study that will include up to 15,000 patient participants recently diagnosed with type 2 diabetes. The Avantect test is a blood-based assay designed to use key epigenomic and genomic signals to detect the earliest indicators of pancreatic cancer.
More
-
Dec 13 |
*Cardiopulmonary assessment tool detects and monitors digital biomarkers to support health management and help improve therapeutic outcomes for chronic respiratory disease patients
*electronRx to showcase purpleDx at CES 2025 (7–10 Jan, Las Vegas)
More
-
Dec 13 |
Coronado Research announced today that Dr Jennifer Bradford has been appointed as VP, Head of Data Science.
More
-
Dec 11 |
Indica Labs today announces that the Institute of Tissue Medicine and Pathology at the University of Bern has selected HALO AP® for the Institute’s first-in-country digital pathology deployment in the cloud powered by Amazon Web Services, Inc.
More
-
Dec 10 |
PathAI, a leader in AI-powered pathology solutions, today announced the launch of the AIM-IHC Breast Panel, a set pf advanced AI-assisted, algorithms designed to quantify critical breast cancer biomarkers—HER2, ER, PR, and Ki-67.
More
-
Dec 10 |
Phastar, a global specialist biometrics contract research organization (CRO), has won the Best CRO - Specialist Providers category at the 2024 Scrip Awards.
More
View more articles